|MRI-guided focused ultrasound ablation for localized intermediate-risk prostate cancer: early results of a phase II trial|
S Ghai, A Finelli, K Corr, R Chan, S Jokhu, X Li, S McCluskey, ...
Radiology 298 (3), 695-703, 2021
|A comparative study of tests for homogeneity of variances with application to DNA methylation data|
X Li, W Qiu, J Morrow, DL DeMeo, ST Weiss, Y Fu, X Wang
PloS one 10 (12), e0145295, 2015
|Sampling frequency of fetal heart rate impacts the ability to predict pH and BE at birth: a retrospective multi-cohort study|
X Li, Y Xu, C Herry, LD Durosier, D Casati, T Stampalija, E Maisonneuve, ...
Physiological measurement 36 (5), L1, 2015
|Differentiated population structure of a genetically depauperate mangrove species Ceriops tagal revealed by both Sanger and deep sequencing|
Y Huang, C Zhu, X Li, X Li, L Hu, F Tan, R Zhou, S Shi
Aquatic Botany 101, 46-54, 2012
|De novo assembly of the transcriptomes of two yellow mangroves, Ceriops tagal and C. zippeliana, and one of their terrestrial relatives, Pellacalyx yunnanensis|
Y Yang, S Yang, J Li, X Li, C Zhong, Y Huang, R Zhou, S Shi
Marine genomics 23, 33-36, 2015
|Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer|
S Lheureux, DE Matei, PA Konstantinopoulos, BX Wang, R Gadalla, ...
Journal for immunotherapy of cancer 10 (3), 2022
|The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma|
SR Kim, J Malcolmson, X Li, MQ Bernardini, L Hogen, T May
Gynecologic Oncology 162 (3), 702-706, 2021
|Phase II trial assessing niraparib with or without dostarlimab (anti-PD-1) in recurrent endometrial carcinoma.|
A Madariaga, S Garg, N Tchrakian, NC Dhani, W Jimenez, S Welch, ...
Journal of Clinical Oncology 39 (15_suppl), 5574-5574, 2021
|Updating reports of phase 3 clinical trials for cancer|
E Elimova, S Moignard, X Li, M Yu, W Xu, B Seruga, IF Tannock
JAMA oncology 7 (4), 593-596, 2021
|Robust joint score tests in the application of DNA methylation data analysis|
X Li, Y Fu, X Wang, W Qiu
BMC bioinformatics 19, 1-11, 2018
|Repurposing itraconazole and hydroxychloroquine to target lysosomal homeostasis in epithelial ovarian cancer|
S Marastoni, A Madariaga, A Pesic, SN Nair, ZJ Li, Z Shalev, T Ketela, ...
Cancer Research Communications 2 (5), 293-306, 2022
|Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences|
A Madariaga, G Bhat, MK Wilson, X Li, S Cyriac, V Bowering, W Hunt, ...
American Journal of Obstetrics and Gynecology 225 (6), 658. e1-658. e9, 2021
|Quality of patient‐reported outcomes in oncology clinical trials using immune checkpoint inhibitors: A systematic review|
E Malone, R Barua, N Meti, X Li, R Fazelzad, AR Hansen
Cancer Medicine 10 (15), 5031-5040, 2021
|Phase I/II trial assessing hydroxychloroquine and itraconazole in women with advanced platinum-resistant epithelial ovarian cancer (EOC)(HYDRA-01).|
A Madariaga, S Marastoni, I Colombo, V Mandilaras, M Cabanero, ...
Journal of Clinical Oncology 38 (15_suppl), 6049-6049, 2020
|Detecting Differentially Variable MicroRNAs via Model-Based Clustering|
X Li, Y Fu, X Wang, DL DeMeo, K Tantisira, ST Weiss, W Qiu
International Journal of Genomics 2018, 2018
|Perioperative outcomes and survival in elderly women with ovarian cancer|
S Dong, L Hogen, L Romanovsky, S Alibhai, M Bernardini, T May, ...
Gynecologic Oncology 162, S232-S233, 2021
|Research biopsies in gynecologic oncology: patients’ perspective|
A Madariaga, G Bhat, X Li, M Wilson, S Cyriac, V Bowering, W Hunt, ...
Gynecologic Oncology 162, S261-S262, 2021
|Assessing cultural and linguistic diversity and distress screening completion in gynecologic oncology patients (iCALD)|
L Kasherman, V Bowering, X Li, G Bouchard-Fortier, J Croke, J Lau, ...
Gynecologic Oncology 162, S91-S92, 2021
|A Method for Clustering Hemaglutinin Influenza Protein Sequences|
X Li, J Jankowski, H., Wang, X., Heffernan
BIOMAT 2014 Proceedings, 2014